MedPath

FSH-R : Diagnostic Application for Localized Tumors in Cancerology

Not Applicable
Terminated
Conditions
Cancer
Interventions
Procedure: blood sample for FSHR analysis
Registration Number
NCT02860481
Lead Sponsor
Institut Curie
Brief Summary

FRACTal study is the first exploration of detection of FSHR as a blood biomarker for the diagnosis of cancer.

A first cohort will explore several common (e.g. breast, prostate) or rare (e.g. uveal melanoma) cancers, that are frequently treated at Institut Curie. This first cohort will include n=10 patients per histological type except for breast cancer (n=50). 100 patients are expected in this cohort.

A second cohort will explore the more promising histological type (if any) in term of incidence of detection. 100 patients are expected for this second cohort.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
95
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
second cohort : 100 patientsblood sample for FSHR analysisPatients with breast cancer of with ovarian and/or endometrial cancer
first cohort : first 100 patientsblood sample for FSHR analysisfirst cohort : first 100 patients 10 patients with ovarian and/or endometrial cancer 10 patients with colorectal cancer 10 patients with head and neck cancer 10 patients with uveal melanoma 40 patients with invasive breast cancer 10 patients with breast ductal carcinoma in situ 10 patients with other tumor type
Primary Outcome Measures
NameTimeMethod
sensitivity of blood FSH R detection in cancer patientsend of the study, up to two years
Secondary Outcome Measures
NameTimeMethod
comparison of blood FSH-R with blood from healthy donorend of the study, up to two years
variability of blood FSH-R in the same tumoral type and between different tumoral typesend of the study, up to two years

Trial Locations

Locations (2)

Centre René Huguenin

🇫🇷

Saint Cloud, France

Institut Curie

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath